DANBURY, Conn., May 24, 2023 (GLOBE NEWSWIRE) — MannKind Corporation MNKD, a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced Burkhard Blank, MD, has joined the company as Executive Vice President, Research & Development and Chief…Read More
Dr Burkhard Blank Joins MannKind as Executive Vice President of Research Development and Chief Medical Officer MannKind NASDAQMNKD
